FDA Approves GSK’s Voltaren Arthritis Pain for Over-the-Counter Use in the United States

Warren, New Jersey, USA — February 17, 2020 — GlaxoSmithKline (LSE/NYSE: GSK) today announced that the U.S. Food and Drug Administration (FDA) has approved Voltaren Arthritis Pain (diclofenac sodium topical gel, 1% (NSAID)- arthritis…Original Article